Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Lab on a Chip|February 18, 2015
Circulating tumor cell detection using a parallel flow micro-aperture chip systemChun-Li Chang, Wanfeng Huang, Shadia I Jalal, et al.Journal of Cachexia, Sarcopenia and Muscle|July 7, 2018
Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancerJoshua K Kays, Safi Shahda, Melissa Stanley, et al.Cancers|December 18, 2020
Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery PlatformAshok Narasimhan, Safi Shahda, Joshua K Kays, et al.The Oncologist|August 18, 2018
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid TumorsGregory L Beatty, Safi Shahda, Thaddeus Beck, et al.Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
A Phase I study targeting the APE1/Ref-1 redox signaling protein with APX3330: First clinical agent targeting APE1/Ref-1 in CancerMark R Kelley, Jun Wan, Sheng Liu, et al.Investigational New Drugs|July 25, 2019
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancerS Lindsey Davis, Dana B Cardin, Safi Shahda, et al.The American Journal of Gastroenterology|February 1, 2017
A Multidisciplinary Approach to Pancreas Cancer in 2016: A ReviewEvan L Fogel, Safi Shahda, Kumar Sandrasegaran, et al.Molecular Cancer Therapeutics|August 19, 2016
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer ModelsDerek P Logsdon, Michelle Grimard, Meihua Luo, et al.Cancer Immunology, Immunotherapy : CII|June 23, 2021
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186Cameron J Herting, Matthew R Farren, Yan Tong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic CancerEfrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.Pageof 4